B. Riley Weighs in on CryoPort Inc’s FY2021 Earnings (CYRX)
CryoPort Inc (NASDAQ:CYRX) – Analysts at B. Riley upped their FY2021 earnings estimates for CryoPort in a research report issued on Friday, November 9th. B. Riley analyst A. D’silva now anticipates that the consumer goods maker will post earnings of $0.24 per share for the year, up from their prior estimate of $0.23. B. Riley currently has a “Buy” rating and a $22.00 target price on the stock.
CryoPort (NASDAQ:CYRX) last issued its quarterly earnings data on Thursday, November 8th. The consumer goods maker reported ($0.07) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.01. CryoPort had a negative return on equity of 40.81% and a negative net margin of 55.44%. The firm had revenue of $5.30 million for the quarter, compared to analyst estimates of $5.06 million. During the same period in the prior year, the firm posted $0.08 EPS. The company’s revenue for the quarter was up 76.7% on a year-over-year basis.
NASDAQ:CYRX opened at $10.41 on Monday. CryoPort has a fifty-two week low of $6.02 and a fifty-two week high of $16.88.
Institutional investors and hedge funds have recently modified their holdings of the business. Schwab Charles Investment Management Inc. acquired a new position in CryoPort in the 2nd quarter worth about $864,000. Greenwood Capital Associates LLC acquired a new position in CryoPort in the 2nd quarter worth about $163,000. Granahan Investment Management Inc. MA increased its holdings in CryoPort by 15.8% in the 2nd quarter. Granahan Investment Management Inc. MA now owns 203,343 shares of the consumer goods maker’s stock worth $3,209,000 after purchasing an additional 27,749 shares in the last quarter. MetLife Investment Advisors LLC acquired a new position in CryoPort in the 2nd quarter worth about $192,000. Finally, FNY Investment Advisers LLC acquired a new position in CryoPort in the 3rd quarter worth about $147,000. 49.08% of the stock is owned by institutional investors and hedge funds.
In related news, Director Richard J. Berman sold 10,000 shares of the company’s stock in a transaction on Thursday, September 6th. The stock was sold at an average price of $14.00, for a total transaction of $140,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 9.60% of the stock is owned by corporate insiders.
CryoPort Company Profile
Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.